NCT04096794Recruiting
Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research
Source: ClinicalTrials.gov · Last updated 21 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 2 Sept 2019
- Start date
- Sept 2016
- Primary completion date
- Sept 2027
- Lead sponsor
- Second Xiangya Hospital of Central South University
- Diseases
- Type 1 diabetes
- NCT number
- NCT04096794
What you commit to
- Study type: Observational
- Planned participants: 500
- From Sept 2016 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
- With mental disorders
- Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial
Who the study is looking for
- Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
- Written informed consent from the patient or family representative;
- Individuals who own smartphone and are capable of using wechat or apps
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.